This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast on material and device regulation and why we should ask more questions about device representatives’ intraoperative roles during implantations. Featured guests…
In this video edition of Ethics Talk, journal editor-in-chief Dr Audiey Kao talks with Drs Alicia Best and Faith Fletcher about building trustworthiness by advancing equity and inclusion in bioethics and public health.
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast on how economic decision modeling and value analyses can help reduce waste in health care spending and improve patient care. Featured…
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast on patient experiences with chronic pain and how physical therapy can be used for good migraine headache care. Featured guests are…
In this video edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Olivia Kates about appropriate use of antibiotics during the COVID-19 pandemic.
In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Prof Ana Santos Rutschman about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast about how transgenerational trauma can help clinicians motivate health equity, especially among historically marginalized groups like Native American and First Nations…
This article analyzes differences in prescription drug pricing transparency practices among 3 Organization for Economic Co-operation and Development member nations: the United Kingdom, Germany, and Canada. Specifically, this article compares these countries’ policies on list and net price disclosures and…
In health care, lack of transparency about the cost of health care services to patients during clinical encounters has contributed to increased costs and high out-of-pocket expenses. Federal policy has responded to the need for more transparency and spurred discussion…
Negative health consequences stemming from the financial burden of care on patients and their loved ones are documented as financial toxicity in the literature, and these consequences should be included in informed consent discussions during patient-clinician interactions. However, codes of…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
